| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |